PCM
DPLO

Palisade Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Palisade Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-639,655
Closed -$8.61M – 465
2018
Q4 		$8.61M Buy
639,655
+9,538
+2% +$161K 0.32% 109
2018
Q3 		$12.2M Buy
630,117
+123,334
+24% +$2.63M 0.34% 93
2018
Q2 		$13M Buy
506,783
+138,938
+38% +$3.24M 0.37% 83
2018
Q1 		$7.41M Buy
367,845
+139,174
+61% +$3.25M 0.25% 132
2017
Q4 		$4.59M Buy
+228,671
New +$4.5M 0.16% 190
2016
Q1 		– Sell
-60,960
Closed -$2.09M – 561
2015
Q4 		$2.09M Buy
60,960
+40,960
+205% +$1.28M 0.07% 335
2015
Q3 		$575K Buy
+20,000
New +$855K 0.02% 455
2015
Q2 		– Sell
-15,000
Closed -$519K – 548
2015
Q1 		$519K Buy
+15,000
New +$408K 0.01% 443

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Palisade Capital Management's DPLO Position: Q1 2019 in Review

Palisade Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 639,655 shares — an estimated $8.61M sold.

Palisade Capital Management first reported a position in DPLO in Q1 2015 and held it in 8 quarters. The position peaked at $13M in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Palisade Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • Palisade Capital Management sold 639,655 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $8.61M.
  • Palisade Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 8 quarters.
  • Palisade Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $13M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Palisade Capital Management's 13F filing for Q1 2019, filed 13 May 2019.